Clinical trial
Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute…
NCT00081822 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00081822 |
|---|---|
| Title | Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia |
| Official title | A Phase I Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | clofarabine, Ara-C |
| Enrollment | 23 |
| Start date | Jan 1, 2004 |
| Primary completion | Apr 1, 2009 |
| Completion | Aug 1, 2011 |
| First posted | Apr 23, 2004 |
| Last update posted | Apr 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: